These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 40852)

  • 1. [Results of topical therapy with Etofenamat in rheumatic diseases and sports injuries. Report on a seminar on Etofenamat (Rheumon Gel) during the 28th German Congress for Continuing Medical Education, 5-9 June 1979 in Berlin].
    Fortschr Med; 1979 Sep; 97(36):(1586). PubMed ID: 40852
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with a new percutaneously effective antirheumatic preparation].
    Huber M
    Fortschr Med; 1977 Sep; 95(36):2209-10. PubMed ID: 334654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Percutaneous therapy of soft tissue rheumatic diseases. Clinical trials of the non-steroid anti-phlogistic agent Rheumon gel].
    Podzich M
    ZFA (Stuttgart); 1982 Jun; 58(16):921-4. PubMed ID: 7051600
    [No Abstract]   [Full Text] [Related]  

  • 4. [Etofenamate (Rheumon gel). Quickly effective, risk-reduced rheumatism therapy through cutaneous application].
    ZFA (Stuttgart); 1980 May; 56(13):939-41. PubMed ID: 6968132
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effectiveness of etofenamate in minor sports injuries of the knee and ankle joint. A double-blind study].
    Ascherl R; Schlemmer H; Blümel G; Lechner F
    Fortschr Med; 1982 Oct; 100(37):1729-34. PubMed ID: 7173777
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with etofenamate in sport injuries (author's transl)].
    Waterloh E; Groth KH
    Arzneimittelforschung; 1977; 27(6B):1355-7. PubMed ID: 579125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the effect of etofenamate 10% cream in comparison with an oral NSAID in strains and sprains due to sports injuries.
    Vanderstraeten G; Schuermans P
    Acta Belg Med Phys; 1990; 13(3):139-41. PubMed ID: 2094113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience with a locally applicable antirheumatic (author's transl)].
    Klug H
    Arzneimittelforschung; 1977; 27(6B):1350-4. PubMed ID: 336057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma- and tissue concentrations following intramuscular administration of etofenamat. Pharmacokinetics of etofenamat and flufenamic acid in plasma, synovium, and tissues of patients with chronic polyarthritis after administration of an oily solution of etofenamat].
    Köhler G; Tressel W; Dell HD; Doersing M; Fischer W; Kamp R; Langer M; Richter B; Wirzbach E
    Arzneimittelforschung; 1992 Dec; 42(12):1487-91. PubMed ID: 1288513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Report on the 20th German Congress for Continuing Medical Education, the 4th German Continuing Dental Education Congress as well as on the International Pharmaceutical and Medico-technical Exposition June 1-6 1971].
    Oswald KM
    Dtsch Med J; 1971 Sep; 22(17):542-8. PubMed ID: 5111781
    [No Abstract]   [Full Text] [Related]  

  • 11. [Allergic contact dermatitis caused by etofenamate].
    Degenhardt A; Zick C; Hausen BM
    Z Hautkr; 1988 Jun; 63(6):475-8. PubMed ID: 2970161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Topical use of Rheumon-Gel in the combined treatment of patients with rheumatoid arthritis].
    Cherevatov BG; Shelest AN; Volnenko NB; Cherevatova SKh
    Ter Arkh; 1987; 59(12):100-2. PubMed ID: 3447280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact dermatitis from etofenamate.
    Götze A; Teikemeier G; Goerz G
    Contact Dermatitis; 1992 Mar; 26(3):209. PubMed ID: 1387064
    [No Abstract]   [Full Text] [Related]  

  • 14. [Scientific programme of the 20th German Congress for Continuing Medical Education in Berlin June 1-6 1971].
    von Mikulicz-Radecki JG
    Dtsch Med J; 1971 Sep; 22(17):549-55. PubMed ID: 5111782
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of the new percutaneously active antirheumatic etofenamate. Summarising report (author's transl)].
    Heindl I; Lorenz D; Sieberns S; Blumberger W
    Arzneimittelforschung; 1977; 27(6B):1357-63. PubMed ID: 144509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with a transcutaneously effective antirheumatic agent (Etofenamate). Results of a field study on 7,863 patients].
    Tepe HJ; Blumberger W
    Med Welt; 1978 Mar; 29(11):448-51. PubMed ID: 306482
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of a salicylate-heparin gel with a monosubstance preparation. Results of a double-blind cross-over study].
    Geller O
    MMW Munch Med Wochenschr; 1980 Sep; 122(36):1231-2. PubMed ID: 6777681
    [No Abstract]   [Full Text] [Related]  

  • 18. [Testing the efficiency of ointments containing flufenamic acid in rheumatic diseases in a controlled trial].
    Frankhof W; Thiemer K
    ZFA (Stuttgart); 1976 Jan; 52(1):50-2. PubMed ID: 1083601
    [No Abstract]   [Full Text] [Related]  

  • 19. [Allergic contact eczema to etofenamate and dwarf pine oil].
    Knöll R; Ulrich R; Spallek W
    Sportverletz Sportschaden; 1990 Jun; 4(2):96-8. PubMed ID: 2143316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacology and toxicology of etofenamate. 1st Communication (author's transl)].
    Jacobi H; Breier P; Dell HD; Lorenz D
    Arzneimittelforschung; 1977; 27(6B):1326-33. PubMed ID: 579122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.